Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients

Abstract : Facioscapulohumeral dystrophy (FSHD) is one of the three most common muscular dystrophies in the Western world, however, its etiology remains only partially understood. Here, we provide evidence of constitutive DNA damage in in vitro cultured myoblasts isolated from FSHD patients and demonstrate oxidative DNA damage implication in the differentiation of these cells into phenotypically-aberrant myotubes. Double homeobox 4 (DUX4), the major actor in FSHD pathology induced DNA damage accumulation when overexpressed in normal human myoblasts, and RNAi-mediated DUX4 inhibition reduced the level of DNA damage in FSHD myoblasts. Addition of tempol, a powerful antioxidant, to the culture medium of proliferating DUX4-transfected myoblasts and FSHD myoblasts reduced the level of DNA damage, suggesting that DNA alterations are mainly due to oxidative stress. Antioxidant treatment during the myogenic differentiation of FSHD myoblasts significantly reduced morphological defects in myotube formation. We propose that the induction of DNA damage is a novel function of the DUX4 protein affecting myogenic differentiation of FSHD myoblasts.
Liste complète des métadonnées

https://hal.umontpellier.fr/hal-01804819
Contributeur : Dominique Mornet <>
Soumis le : mercredi 4 décembre 2019 - 09:02:34
Dernière modification le : jeudi 19 décembre 2019 - 01:34:01
Document(s) archivé(s) le : jeudi 5 mars 2020 - 13:50:43

Fichier

2016 Dimitriev et al., DUX4 in...
Fichiers produits par l'(les) auteur(s)

Identifiants

Citation

Petr Dmitriev, Yara Bou Saada, Carla Dib, Eugénie Ansseau, Ana Barat, et al.. DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients. Free Radical Biology and Medicine, Elsevier, 2016, 99, pp.244 - 258. ⟨10.1016/j.freeradbiomed.2016.08.007⟩. ⟨hal-01804819⟩

Partager

Métriques

Consultations de la notice

206

Téléchargements de fichiers

83